莱维-MSA混合折叠驱动了独特的神经元α-synuclein病理
Masahiro Enomoto1, Ivan Martinez-Valbuena2, Shelley L Forrest2
1Princess Margaret Cancer Centre, University Health Network, Toronto, ON, M5G 1L7, Canada.
bioRxiv : the preprint server for biology
|November 28, 2024
概括
阿尔法-同核素蛋白在像莱维体病和多个系统缩等同核素异常症中形成了独特的细丝. 这项研究发现了一种与非典型的MSA相关的新混合折叠,扩大了我们对这些神经退行性疾病的理解.
科学领域:
- 神经科学是一个神经科学.
- 蛋白质生物化学 蛋白质生物化学
- 遗传学 是一个遗传学.
背景情况:
- 合成核蛋白病变,包括勒维体病 (LBD) 和多重系统缩 (MSA),是通过将α-合成核蛋白聚合成纤维来定义的.
- 在LBD,MSA和青少年发病同核素病变 (JOS) 中观察到明显的α-同核素丝结构,这表明结构特定的疾病实体.
- 非典型的MSA呈现出神经元内含,与典型的MSA的寡质细胞病理不同.
研究的目的:
- 研究同核蛋白病变中的α-同核蛋白丝的结构多样性.
- 识别与非典型的MSA病理学形式相关的新型α-synuclein折叠.
- 为了将不同的α-synuclein生物化学特性和丝状结构与细胞病理学差异相关联.
主要方法:
- 低温电子显微镜用于对α-synuclein纤维的结构分析.
- 蛋白酶敏感性消化试验用于评估生物化学特征.
- 种子放大试验 (SAA) 和形状稳定性试验 (CSA) 来评估蛋白质的行为.
- 脑组织病理学检查来自不同同核蛋白病变的患者的大脑组织.
主要成果:
- 阿尔法-同核素可以在此前识别的MSA折叠之外形成一个新的Lewy-MSA混合折叠.
- 这种混合折叠与MSA的非典型体质病理表现有关.
- 独特的生物化学性质 (蛋白酶敏感性,SAA,CSA) 与观察到的细胞病理差异 (神经与寡基质) 相相关.
结论:
- 这项研究扩展了基于结构的同核蛋白病变的分类.
- 不同的α-synuclein丝折叠与特定的疾病亚型和细胞病理有关.
- 在同核蛋白病变中,细胞特异性蛋白质病理可能来自不同的α-同核蛋白丝结构.
相关概念视频
03:03Amyloid Fibrils
9.2K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.2K
01:37Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
01:15Parkinson's Disease: Overview
482
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
482
01:22Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K